glp 1 glucagon Science Behind GIP and Receptor Agonists for Obesity Research | News & Announcements Central glucagon-like peptide 1 receptor

As future doctors, we are taught to always warn patients on sulfonylureas about hypoglycemia symptoms shakiness, sweating, confusion and to always carry sugar with them. Mohammad Junaid Rain, MBBS 2nd Year Key advantages of Sulfonylureas: Very affordable 30100/month in India Available everywhere even in small town pharmacies Strong blood sugar lowering effect Decades of safety data Key disadvantages: Hypoglycemia risk can cause dangerous low blood sugar Weight gain 24 kg on average Beta cell burnout with long term use, pancreas gets more exhausted Not ideal for elderly patients or those who skip meals Hypoglycemia warning signs to tell your patients: What to do: Immediately eat 23 teaspoons of sugar or drink a glass of fruit juice

Advertisement While we make progress on all these other CVD risk factors, obesity has continued unabated, says A

Tell your story

During the first 48-hour burst release stage exenatide is released from the surface and surface pores of the microspheres

Raparelli, V., et al

Dual GLP-1/GIP receptor agonists possess distinct pharmacodynamic and metabolic profiles, and long-term oncological safety data for these agents remain limited